MODIFIED T-CELLS FOR USE IN THE TREATMENT OF BLADDER CANCER

The disclosure relates to a method of treating bladder cancer, and to a population of modified immunoresponsive cells expressing a heterologous TCR for use in such method. L'invention concerne une méthode de traitement du cancer de la vessie, et une population de cellules immunoréactives modifi...

Full description

Saved in:
Bibliographic Details
Main Authors GARCIA-CONSUEGRA LÓPEZ-PICAZO, Alejandro, SARO SUAREZ, José María, DAWE, Stephen
Format Patent
LanguageEnglish
French
Published 14.03.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to a method of treating bladder cancer, and to a population of modified immunoresponsive cells expressing a heterologous TCR for use in such method. L'invention concerne une méthode de traitement du cancer de la vessie, et une population de cellules immunoréactives modifiées exprimant un TCR hétérologue destinée à être utilisée dans une telle méthode.
Bibliography:Application Number: WO2023GB52305